Get the Stockscreener App
1.74
6.49%
-0.11
Alto Neuroscience Inc Stock (ANRO) Forecast
The Alto Neuroscience Inc (ANRO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.20, representing a +716.06% increase from the current price of $1.74. The highest analyst price target is $16.58, and the lowest is $11.82.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ANRO Price Target
Average 15.72
(+803.49% Upside)
Is Alto Neuroscience Inc (ANRO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 21.49 | Buy |
| STOCH(9,6) | 5.4453 | Buy |
| STOCHRSI(14) | 6.7438 | Buy |
| MACD(12,26) | -0.3877 | Sell |
| ADX(14) | 28.45 | Sell |
| William %R | -90.79 | Buy |
| CCI(14) | -87.00 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.218
Sell
|
2.1833
Sell
|
| MA20 |
2.639
Sell
|
2.5022
Sell
|
| MA50 |
3.1926
Sell
|
3.1422
Sell
|
| MA100 |
3.7277
Sell
|
4.3701
Sell
|
| MA200 |
7.4492
Sell
|
6.9982
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ANRO could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on ANRO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 21.49 indicates that ANRO is oversold. This indicates that ANRO price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 5.4453 indicates that ANRO is oversold. This indicates that ANRO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.7438 indicates that ANRO is oversold. This suggests that ANRO price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.45 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -87 indicates that ANRO is still oversold but not to an extreme extent.
Long-term ANRO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Alto Neuroscience Inc financial reports and earnings history, Alto Neuroscience Inc (ANRO) stock could reach $7.7634 by 2030, $9.0964 by 2040 and $24.06 by 2050. See the projected annual prices until 2050 of the Alto Neuroscience Inc stock below:
- Alto Neuroscience Inc (ANRO) is expected to reach an average price of $3.185 in 2035, with a high prediction of $1.048 and a low estimate of $2.646. This indicates an $83.05% rise from the last recorded price of $1.74.
- Alto Neuroscience Inc (ANRO) stock is projected to chart a bullish course in 2040, with an average price target of $10.03, representing an $476.51% surge from its current level. The forecast ranges from a conservative $9.0511 to a sky-high $9.0964.
- Our analysts predict Alto Neuroscience Inc (ANRO) to jump 873.01% by 2045, soaring from $16.59 to an average price of $16.93, potentially reaching $15.39. While $16.59 is the low estimate, the potential upside is significant.
- Alto Neuroscience Inc (ANRO) stock is expected to climb by 2050, reaching an average of $24.02, a $1,280% jump from its current level. However, a wide range of estimates exists, with high and low targets of $24.06 and $25.88, respectively, highlighting the market's uncertainty.
Alto Neuroscience Inc Stock (ANRO) Year by Year Forecast
Alto Neuroscience Inc Stock (ANRO) Price Forecast for 2025
Alto Neuroscience Inc Stock (ANRO) is expected to reach an average price of $16.17 in 2025, with a high prediction of $22.20 and a low estimate of $10.13. This indicates an +829.13% rise from the last recorded price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $12.50 | $11.82 | $16.58 | +618.54% |
| June, 2025 | $12.90 | $11.02 | $14.78 | +641.28% |
| July, 2025 | $12.65 | $10.59 | $21.75 | +626.80% |
| August, 2025 | $13.13 | $11.29 | $16.13 | +654.75% |
| September, 2025 | $11.98 | $10.57 | $13.14 | +588.44% |
| October, 2025 | $11.03 | $10.14 | $21.30 | +533.90% |
| November, 2025 | $13.14 | $10.84 | $14.38 | +655.14% |
| December, 2025 | $10.31 | $10.13 | $15.69 | +492.75% |
Alto Neuroscience Inc Stock (ANRO) Price Forecast for 2026
The predicted value for Alto Neuroscience Inc (ANRO) in 2026 is set at an average of $14.60. Estimates vary from a peak of $20.85 to a trough of $8.3463, indicating an +738.97% surge from the present price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $13.40 | $10.24 | $20.85 | +670.11% |
| February, 2026 | $11.75 | $9.6914 | $14.26 | +575.45% |
| March, 2026 | $12.25 | $10.39 | $15.25 | +603.77% |
| April, 2026 | $12.43 | $9.6926 | $13.21 | +614.61% |
| May, 2026 | $10.13 | $9.2431 | $20.40 | +482.36% |
| June, 2026 | $12.25 | $9.9476 | $13.49 | +603.97% |
| July, 2026 | $9.4318 | $9.2516 | $14.80 | +442.06% |
| August, 2026 | $12.50 | $9.3583 | $19.95 | +618.39% |
| September, 2026 | $9.7467 | $8.7947 | $13.36 | +460.16% |
| October, 2026 | $10.54 | $9.544 | $14.36 | +505.52% |
| November, 2026 | $11.56 | $8.8106 | $12.34 | +564.11% |
| December, 2026 | $10.92 | $8.3463 | $19.50 | +527.84% |
Alto Neuroscience Inc Stock (ANRO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Alto Neuroscience Inc (ANRO) is $13.03, with a high forecast of $19.05 and a low forecast of $7.0012. This indicates an +648.60% increase from the last price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $11.53 | $9.0558 | $12.60 | +562.48% |
| February, 2027 | $8.5497 | $8.3695 | $13.92 | +391.36% |
| March, 2027 | $10.92 | $8.439 | $19.05 | +527.53% |
| April, 2027 | $8.8549 | $7.8979 | $12.15 | +408.90% |
| May, 2027 | $9.6508 | $8.6538 | $13.47 | +454.64% |
| June, 2027 | $9.8196 | $7.9285 | $11.71 | +464.34% |
| July, 2027 | $10.03 | $7.4496 | $18.60 | +476.40% |
| August, 2027 | $10.64 | $8.1639 | $11.71 | +511.41% |
| September, 2027 | $8.8975 | $7.4875 | $13.03 | +411.35% |
| October, 2027 | $10.02 | $7.5406 | $18.15 | +475.90% |
| November, 2027 | $7.963 | $7.0012 | $11.26 | +357.64% |
| December, 2027 | $8.526 | $7.7636 | $12.58 | +390.00% |
Alto Neuroscience Inc Stock (ANRO) Price Forecast for 2028
In 2028, Alto Neuroscience Inc (ANRO) is projected to reach an average price of $11.45, with a high projection of $17.70 and a low estimate of $5.2077. This indicates an +558.27% rise from the last price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.94 | $7.0464 | $10.83 | +413.79% |
| February, 2028 | $9.1343 | $6.5528 | $17.70 | +424.96% |
| March, 2028 | $9.1414 | $7.2721 | $12.14 | +425.37% |
| April, 2028 | $8.017 | $6.6054 | $9.1528 | +360.75% |
| May, 2028 | $6.9945 | $6.1045 | $17.25 | +301.98% |
| June, 2028 | $9.1334 | $6.8262 | $10.37 | +424.91% |
| July, 2028 | $7.6424 | $6.9356 | $11.70 | +339.22% |
| August, 2028 | $9.35 | $6.1644 | $16.80 | +437.36% |
| September, 2028 | $7.7322 | $5.6561 | $10.21 | +344.38% |
| October, 2028 | $8.2544 | $6.3803 | $11.25 | +374.39% |
| November, 2028 | $8.4797 | $5.7234 | $9.2597 | +387.34% |
| December, 2028 | $6.0977 | $5.2077 | $16.35 | +250.44% |
Alto Neuroscience Inc Stock (ANRO) Price Forecast for 2029
The 2029 price forecast for Alto Neuroscience Inc Stock (ANRO) is $9.8813 on average, with a high prediction of $15.90 and a low estimate of $3.8626. This represents an +467.89% increase from the previous price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.4171 | $5.9343 | $9.4793 | +383.74% |
| February, 2029 | $5.4625 | $5.2823 | $10.81 | +213.94% |
| March, 2029 | $8.45 | $5.3964 | $15.90 | +385.63% |
| April, 2029 | $6.8387 | $4.7594 | $9.3147 | +293.03% |
| May, 2029 | $6.5521 | $5.4884 | $10.37 | +276.56% |
| June, 2029 | $7.6009 | $4.8413 | $8.3809 | +336.83% |
| July, 2029 | $5.201 | $4.311 | $15.45 | +198.91% |
| August, 2029 | $7.5285 | $5.0425 | $8.5875 | +332.67% |
| September, 2029 | $4.5805 | $4.4003 | $9.9239 | +163.25% |
| October, 2029 | $6.8763 | $4.3963 | $15.00 | +295.19% |
| November, 2029 | $4.8416 | $3.8626 | $8.1416 | +178.25% |
| December, 2029 | $5.6668 | $4.6479 | $9.4804 | +225.68% |
Alto Neuroscience Inc Stock (ANRO) Price Forecast for 2030
Alto Neuroscience Inc Stock (ANRO) is expected to reach an average price of $8.5338 in 2030, with a high forecast of $14.55 and a low forecast of $2.5175. This signifies an +390.45% surge from the last price of $1.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.8613 | $3.9593 | $7.7634 | +236.86% |
| February, 2030 | $6.0014 | $3.4143 | $14.55 | +244.91% |
| March, 2030 | $6.6399 | $4.1506 | $7.6956 | +281.60% |
| April, 2030 | $3.6984 | $3.5182 | $9.0369 | +112.55% |
| May, 2030 | $5.9779 | $3.4979 | $14.10 | +243.56% |
| June, 2030 | $3.9497 | $2.9659 | $7.2497 | +127.00% |
| July, 2030 | $4.5495 | $3.7577 | $8.5935 | +161.46% |
| August, 2030 | $4.9817 | $3.0772 | $6.8862 | +186.31% |
| September, 2030 | $5.1063 | $2.5175 | $13.65 | +193.46% |
| October, 2030 | $5.1501 | $3.2588 | $8.15 | +195.98% |
| November, 2030 | $4.0551 | $2.6362 | $5.1689 | +133.05% |
| December, 2030 | $5.0796 | $2.5996 | $13.20 | +191.93% |
2.65%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):